US Stock MarketDetailed Quotes

BRTX Biorestorative Therapies

Watchlist
  • 2.290
  • -0.170-6.91%
Close Feb 14 16:00 ET
15.85MMarket Cap-1.60P/E (TTM)
Full Hours
  • 5D
  • Daily
  • Weekly
  • Monthly
  • 1Q
  • 1Y

Trade Overview

Unit: --

Capital Trend

IntradayDayWeekMonth

No Data

Comments

    $Biorestorative Therapies (BRTX.US)$
    BRTX-100 Front and Center at ORS 2025
    BioRestorative Therapies (NASDAQ:BRTX) presented new blinded preliminary data from its Phase 2 clinical trial of BRTX-100 at the Orthopaedic Research Society annual meeting. The data, now covering 15 patients with chronic lumbar disc disease (cLDD), showed significant improvements:
    - Pain reduction (VAS): 71.20% at 26 weeks and 73.58% at 52 weeks
    - Function improvement (ODI): 69.04% at 26 weeks and 65.16% at 52 weeks
    -...
    $Biorestorative Therapies (BRTX.US)$ BRTX-100 Front and Center at ORS 2025
    GlobeNewswire· 9 mins ago
    – New blinded preliminary BRTX-100 data described this past Saturday at prestigious "2025 Winners in Industry Innovations in MSK Health" presentation –
    – Among other positive preliminary data analyses, comparison of MRI images to baseline potentially demonstrate disc microenvironment remodeling –
    MELVILLE, N.Y., Feb. 10, 2025 (GLOBE NEWSWIRE) -- BioRestorative Therapies, Inc. ("BioRestorativ...
    $Biorestorative Therapies (BRTX.US)$ Reuters
    Just
    BioRestorative Therapies Announces Notice of Allowance of Key New Patent Protecting Thermostem® Metabolic Disease Program
    2
    $Biorestorative Therapies (BRTX.US)$
    BioRestorative Therapies Announces Notice of Allowance of Key New Patent Protecting ThermoStem® Metabolic Disease Program
    Thursday, 5th December at 6:45 am
    – Covers cGMP manufacturing processes –
    – Expected to provide protection until April 29, 2040 –
    MELVILLE, N.Y., Dec. 05, 2024 (GLOBE NEWSWIRE) -- BioRestorative Therapies, Inc. ("BioRestorative", "BRTX" or the "Company") (NASDAQ: BRTX), a clinical stage regenerative medicine innovator focused on stem...
    $Biorestorative Therapies (BRTX.US)$
    BioRestorative Therapies Reports Positive Preliminary Phase 2 BRTX-100 Clinical Data
    5 minutes ago, 4:00 AM PST
    Via GlobeNewswire
    – Blinded preliminary data demonstrate a positive trend and clear signal in Primary and Secondary endpoints –
    – Patient reported efficacy outcomes show a material decrease in pain and increase in function –
    – If positive trends continue, Company confident that the Phase 2 trial will meet its Primary and Secondary end points -
    ...
Read more
Trending Stocks
U.S Tech Companies U.S Tech Companies

U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data. U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data.